MK-677 (Ibutamoren)
CAS 159634-47-6
Product Description
Sarm Mk-677 Ibutamoren with high popularity
Ibutamoren (INN) (developmental code names MK-677, MK-0677, L-163,191) is a non-peptidic, potent, long-acting, orally-active, and selective agonist of the ghrelin receptor and a growth hormone secretagogue,[3][4] mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin.[5][6] It has been demonstrated to increase the release of, and produces sustained increases in plasma levels of several hormones including GH and insulin-like growth factor 1 (IGF-1), but without affecting cortisol levels.[7] MK677 has shown to sustain activation of GH-IGF-1 Axis and increase in lean body mass but no change in total fat mass or visceral fat. It is currently under development as a potential treatment for reduced levels of these hormones, such as in children or elderly adults with growth hormone deficiency,[8][9][10] and human studies have shown it to increase both muscle mass and bone mineral density,[11][12] making it a promising therapy for the treatment of frailty in the elderly
1.Ibutamoren mesylate//mk-677
Oral replacement for research peptides
Easy to dose oral SARM that boosts GH levels in current studies
Agitate bottle before each administration
Not for human consumption
2.Description of ibutamoren:
Formula: 2-Amino-2-methyl-N-[1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-(phenylmethoxy)propan-2-yl]propanamide
Formula: C27H36N4O5S
Mol. weight: 624.77
PubChem: CID 9939050
Molecular Structure:
3.Synonyms:
Ibutamoren, MK-677, Ibutamoren Mesylate, L-163, 191, MK0677
Specificity: MK-677 selectively binds GH secretagogue receptors in certain tissues.
Purity: >99% (HPLC analyzed).
Stability: Store at at 20 °C in dry place until the expiration date.
Source: Chemical Synthesis
China (Mainland)